By Donny Kwok and Yantoultra Ngui HONG KONG/SINGAPORE, Feb 11 (Reuters) - Wuxi Lead Intelligent Equipment closed flat in its ...
Wuxi Lead, which counts CATL, Tesla, and Volkswagen as its customers, is the world's largest lithium-ion battery intelligent equipment provider. It commanded 15.5% of the global market by revenue in ...
Chinese contract drug maker forecasts 46.3% profit rise and signals continued growth despite US political scrutiny WuXi Biologics expects a sharp rise in full-year earnings for 2025, forecasting a 46.
Vertex Pharmaceuticals (NasdaqGS:VRTX) entered an agreement with WuXi Biologics to co-develop a trispecific T-cell Engager for B-cell mediated autoimmune diseases. The collaboration focuses on ...
China-based biologics CDMO WuXi Biologics (HKEX: 2269) has signed a license and research services agreement with US biotech Vertex Pharmaceuticals (Nasdaq: VRTX) covering a preclinical trispecific ...
WuXi Biologics (2269.HK), announced it has been awarded a Platinum Medal by the EcoVadis Sustainability Rating, marking the third year the company has received the rating's highest level of ...
WuXi's bioconjugation spinoff is set to break free onto the Hong Kong Stock Exchange this month, with plans to funnel hundreds of millions of dollars in proceeds back into its Asian manufacturing ...